TSNAX Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q99598 |
---|---|
Clone Names | 90713257 |
Gene ID | 7257 |
---|---|
Other Names | Translin-associated protein X, Translin-associated factor X, TSNAX, TRAX |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13947a was selected from the N-term region of TSNAX. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TSNAX |
---|---|
Synonyms | TRAX |
Function | Acts in combination with TSN as an endonuclease involved in the activation of the RNA-induced silencing complex (RISC). Possible role in spermatogenesis. |
Cellular Location | Cytoplasm, perinuclear region. Golgi apparatus. Nucleus. Note=Accumulate in the Golgi complex of mid- late pachytene spermatocytes (By similarity). Expressed in the cytoplasm in the presence of TSN. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a protein which specifically interactswith translin, a DNA-binding protein that binds consensus sequencesat breakpoint junctions of chromosomal translocations. The encodedprotein contains bipartite nuclear targeting sequences that mayprovide nuclear transport for translin, which lacks any nucleartargeting motifs.
References
Saus, E., et al. J Psychiatr Res 44(14):971-978(2010)Schosser, A., et al. Mol. Psychiatry 15(8):844-849(2010)Okuda, A., et al. Neuromolecular Med. 12(1):78-85(2010)Nakata, K., et al. Proc. Natl. Acad. Sci. U.S.A. 106(37):15873-15878(2009)Palo, O.M., et al. Hum. Mol. Genet. 16(20):2517-2528(2007)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.